An engineered virus kills cancer cells more effectively than another virus currently used in treatments, according to Hokkaido University researchers.
Hokkaido University researchers have engineered a virus that selectively targets and kills cancer cells. The virus, called dl355, has an even stronger anticancer effect than another engineered virus currently used in clinical practice, according to a study published in the journal Oncology Reports.
Molecular oncologist Fumihiro Higashino and colleagues deleted a gene involved in viral replication, called E4orf6, from a type of adenovirus. The team previously discovered that E4orf6 stabilizes a type of mRNA called ARE-mRNAs in the infected cells enabling viral replication. ARE-mRNAs are known to be stable in stressed cells and cancer cells, but rapidly degrade in normal cells.
In laboratory tests, they found that their modified adenovirus, called dl355, replicated and increased its number significantly more in cancer cells than it did in normal cells. Higashino explains “The E4orf6-lacking virus relies on the stable ARE-mRNAs in cancer cells for its replication.”
Some viruses can be used to treat cancers, as they replicate within the cells until they burst and die. The researchers infected several types of cultured cancer cells with 100 dl355 virus particles per cell and found that nearly all the cancer cells died within seven days. In contrast, most normal cells infected with the virus did not die, even after seven days. Several cancer cell lines managed to survive low doses of dl355, but all cancer cells were killed by the virus as the dose was increased. Tumour growth was also significantly suppressed when dl355 was administered to human tumour cells grown in mice.
Finally, the team compared the anticancer effects of dl355 with another anticancer adenovirus currently used in clinical practice, called dl1520. dl355 replication was higher in all cancer cell lines tested, including cervical and lung cancer cells, and was better at killing all but one type of cancer cell, compared to dl1520. Both viruses only killed very few normal cells.
The findings suggest that dl355 has potential to be an effective anticancer treatment, the team concludes. They suggest enhancing the stabilization of ARE-mRNAs in cancer cells could even further strengthen its effect, but Professor Higashino notes that further research is required. “While we think dl355 has the potential to be an effective treatment method in dealing with many types of cancers, much more research needs to be done. When we think of a timeline, at least five more years of further research may be required, possible more, on top of clinical trials,” Professor Higashino noted.
Learn more: Engineering a cancer-fighting virus
The Latest on: Engineered virus
[google_news title=”” keyword=”engineered virus” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Engineered virus
- When Giants Fight Microscopic Wars: Jumbo Viruses Tackle Superbugson May 11, 2024 at 11:30 pm
In the early 20th century, antibiotics gained widespread recognition as an effective treatment for bacterial infections. In what is deemed as the antibiotic golden age, they were regularly developed ...
- Sangamo Therapeutics Presents Next-Generation Modular Integrase Technology Engineered to Enable Large-Scale Genome Editingon May 9, 2024 at 7:00 am
NDAQ:SGMO) Sangamo Therapeutics Presents Next-Generation Modular Integrase Technology Engineered to Enable Large-Scale Genome Editing ...
- Parents stunned as British toddler who was deliberately given virus can finally hearon May 9, 2024 at 1:45 am
A British tot is finally able to hear after being the first in the world to trial a new gene therapy. Opal Sandy is an 18-month-old who was born completely deaf due to a disruption of nerve impulses ...
- Viruses Keep Mice from Stressing Outon May 8, 2024 at 5:00 pm
However, the experimental housing modified the population density of 12 distinct viruses. Corticosterone, a steroid hormone, regulates stress and immune responses, so the researchers assessed levels ...
- Oncolytic Viruses: A Promising New Option in Cancer Treatmenton May 8, 2024 at 7:59 am
As part of its Speaking Out video series, Targeted Oncology spoke with Howard D. Edington, MD, about the benefits of using oncolytic viruses in cancer treatment.
- Research aims to develop vaccine against future COVID viruseson May 6, 2024 at 7:48 am
Scientists are busy working on a vaccine that might fight strains of the COVID virus SARS-CoV-2 that haven't even emerged yet.
- Chinese scientists create mutant Ebola virus in labon May 5, 2024 at 5:00 pm
scientists used a different virus called vesicular stomatitis virus (VSV), which they engineered to carry part of the Ebola virus that's called glycoprotein (GP) that plays a crucial role in helping ...
- No One Knows How Far Bird Flu Has Spreadon May 3, 2024 at 5:26 am
Although the H5N1 virus circulates widely in wild birds ... a 54-year-old New Jersey woman received a genetically engineered pig kidney and thymus after getting a heart pump.
- Research group used U.S. funds for dangerous virus experiments in China labon May 1, 2024 at 1:22 pm
The virus research group EcoHealth Alliance was engaged in dangerous experimental virus work in China that was funded by the federal government, according to a newly released report by a special House ...
- House COVID panel grills EcoHealth Alliance chief, demands criminal probe over virus research in Wuhanon May 1, 2024 at 11:47 am
A House subcommittee investigating the origins of the COVID-19 pandemic urged a criminal investigation of EcoHealth Alliance president Dr. Peter Daszak ahead of a Wednesday hearing, releasing a ...
via Bing News